The popular weight loss drug Wegovy could also improve heart health, a landmark clinical trial has discovered.
This is the first time an obesity drug has been shown to have positive heart benefits for overweight people who don't have diabetes — a finding that could change how Wegovy is prescribed and insured. That's one goal for Novo Nordisk, which said it would file for a"label indication expansion" to make its drug available and covered for reasons beyond weight loss.
The 17,604 participants in the SELECT trial were all over the age of 45 with a history of heart disease, were overweight or obese but not diabetic. Those who were treated with a weekly Wegovy injection versus a placebo experienced the reduction in"major adverse cardiovascular events."
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Weight loss drug Wegovy cuts risk of stroke and heart attack, maker saysThe findings show that the weight-loss drug Wegovy has medical benefits beyond weight reduction, potentially leading to insurance coverage. Dr. Shauna Levy, a specialist in obesity medicine, believes the results are compelling.
Source: TODAYshow - 🏆 389. / 55 Read more »
Wegovy Reduces Risk of Stroke and Heart Attacks, According to CompanyThe weight-loss drug Wegovy has been found to have medical benefits beyond weight reduction, including reducing the risk of stroke and heart attacks. The results may lead to insurance companies providing coverage for the drug, which has previously been seen as a lifestyle medication.
Source: NBCNews - 🏆 10. / 86 Read more »
Study: Weight-loss drug Wegovy cuts heart attack risk in those with obesityA recent study has found that the weight-loss drug Wegovy can significantly reduce the risk of heart attacks in individuals with obesity. This discovery could lead to an increased demand for the drug and strengthen the argument for insurance coverage. Experts emphasize that obesity should be treated as a serious illness due to its association with various health issues, including heart disease. However, private insurers have been hesitant to cover Wegovy, and Medicare is currently prohibited from covering weight-loss medications.
Source: washingtonpost - 🏆 95. / 72 Read more »